• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Development, validation, and implementation of an UHPLC-MS/MS method for the quantitation of furosemide in infant urine samples.建立、验证和应用 UHPLC-MS/MS 法测定婴儿尿液样本中呋塞米的含量。
Biomed Chromatogr. 2022 Mar;36(3):e5262. doi: 10.1002/bmc.5262. Epub 2021 Nov 28.
2
[Determination of eight environmental phenols in human urine samples by high-throughput solid-phase extraction-ultra-performance liquid chromatography-tandem mass spectrometry].[采用高通量固相萃取-超高效液相色谱-串联质谱法测定人尿液样本中的8种环境酚类物质]
Se Pu. 2020 Dec 8;38(12):1456-1464. doi: 10.3724/SP.J.1123.2020.07021.
3
Development and validation of a highly sensitive LC-MS/MS assay for the quantification of arginine vasopressin in human plasma and urine: Application in preterm neonates and child.一种用于定量检测人血浆和尿液中精氨酸加压素的高灵敏度液相色谱-串联质谱法的开发与验证:在早产儿和儿童中的应用。
J Pharm Biomed Anal. 2014 Oct;99:67-73. doi: 10.1016/j.jpba.2014.07.001. Epub 2014 Jul 10.
4
A whole blood microsampling furosemide assay: development, validation and use in a pediatric pharmacokinetic study.全血微采样呋塞米测定法:开发、验证及在儿科药代动力学研究中的应用。
Bioanalysis. 2022 Aug;14(15):1025-1038. doi: 10.4155/bio-2022-0063. Epub 2022 Sep 27.
5
A fast and simple method for the simultaneous analysis of midazolam, 1-hydroxymidazolam, 4-hydroxymidazolam and 1-hydroxymidazolam glucuronide in human serum, plasma and urine.一种快速简便的同时分析人血清、血浆和尿液中咪达唑仑、1-羟基咪达唑仑、4-羟基咪达唑仑和1-羟基咪达唑仑葡萄糖醛酸苷的方法。
J Chromatogr B Analyt Technol Biomed Life Sci. 2021 Jan 1;1162:122476. doi: 10.1016/j.jchromb.2020.122476. Epub 2020 Dec 3.
6
Indacaterol determination in human urine: validation of a liquid-liquid extraction and liquid chromatography-tandem mass spectrometry analytical method.人尿中茚达特罗的测定:液液萃取和液相色谱-串联质谱分析方法的验证
J Aerosol Med Pulm Drug Deliv. 2015 Jun;28(3):202-10. doi: 10.1089/jamp.2014.1153. Epub 2014 Sep 17.
7
Rapid screening of anabolic steroids in horse urine with ultra-high-performance liquid chromatography/tandem mass spectrometry after chemical derivatisation.经化学衍生化后,采用超高效液相色谱/串联质谱法快速筛选马尿中的合成代谢类固醇。
J Chromatogr A. 2012 Apr 6;1232:257-65. doi: 10.1016/j.chroma.2011.12.095. Epub 2012 Jan 10.
8
[Determination of trace -amanitin in urine of mushroom poisoning patient by online solid phase extraction-liquid chromatography-tandem mass spectrometry].在线固相萃取-液相色谱-串联质谱法测定蘑菇中毒患者尿液中的痕量鹅膏毒肽
Se Pu. 2020 Nov 8;38(11):1281-1287. doi: 10.3724/SP.J.1123.2020.03010.
9
A UHPLC-MS/MS bioanalytical assay for the determination of BMS-911543, a JAK2 inhibitor, in human plasma.一种用于测定人血浆中JAK2抑制剂BMS-911543的超高效液相色谱-串联质谱生物分析方法。
J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Jun 1;991:85-91. doi: 10.1016/j.jchromb.2015.04.013. Epub 2015 Apr 17.
10
An UHPLC-MS/MS method for simultaneous quantification of human amyloid beta peptides Aβ1-38, Aβ1-40 and Aβ1-42 in cerebrospinal fluid using micro-elution solid phase extraction.一种使用微洗脱固相萃取同时定量脑脊液中人类淀粉样β肽Aβ1-38、Aβ1-40和Aβ1-42的超高效液相色谱-串联质谱法。
J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Dec 1;1070:82-91. doi: 10.1016/j.jchromb.2017.10.047. Epub 2017 Oct 23.

引用本文的文献

1
A whole blood microsampling furosemide assay: development, validation and use in a pediatric pharmacokinetic study.全血微采样呋塞米测定法:开发、验证及在儿科药代动力学研究中的应用。
Bioanalysis. 2022 Aug;14(15):1025-1038. doi: 10.4155/bio-2022-0063. Epub 2022 Sep 27.

本文引用的文献

1
Assessment of adherence to diuretics and β-blockers by serum drug monitoring in comparison to urine analysis.通过血清药物监测与尿液分析比较评估利尿剂和β受体阻滞剂的依从性。
Blood Press. 2020 Oct;29(5):291-298. doi: 10.1080/08037051.2020.1763775. Epub 2020 May 13.
2
Evaluation of the dose-related concentration approach in therapeutic drug monitoring of diuretics and β-blockers - drug classes with low adherence in antihypertensive therapy.评估利尿剂和β受体阻滞剂治疗药物监测中的剂量相关浓度方法-抗高血压治疗中低依从性的药物类别。
Sci Rep. 2019 Oct 30;9(1):15652. doi: 10.1038/s41598-019-52164-y.
3
Medication use in infants with severe bronchopulmonary dysplasia admitted to United States children's hospitals.美国儿童医院收治的严重支气管肺发育不良婴儿的药物使用情况。
J Perinatol. 2019 Sep;39(9):1291-1299. doi: 10.1038/s41372-019-0415-9. Epub 2019 Jun 21.
4
Patterns of diuretic use in the intensive care unit.利尿剂在重症监护病房的使用模式。
PLoS One. 2019 May 31;14(5):e0217911. doi: 10.1371/journal.pone.0217911. eCollection 2019.
5
Effect of the angiotensin receptor-neprilysin inhibitor sacubitril/valsartan on the pharmacokinetics and pharmacodynamics of a single dose of furosemide.沙库巴曲缬沙坦对单次呋塞米药代动力学和药效学的影响。
Br J Clin Pharmacol. 2018 May;84(5):926-936. doi: 10.1111/bcp.13505. Epub 2018 Feb 20.
6
Development of Tolerance to Chronic Intermittent Furosemide Therapy in Pediatric Patients.儿科患者对慢性间歇性呋塞米治疗的耐受性发展
J Pediatr Pharmacol Ther. 2017 Nov-Dec;22(6):394-398. doi: 10.5863/1551-6776-22.6.394.
7
Compensatory Distal Reabsorption Drives Diuretic Resistance in Human Heart Failure.代偿性远端重吸收导致人类心力衰竭中的利尿剂抵抗。
J Am Soc Nephrol. 2017 Nov;28(11):3414-3424. doi: 10.1681/ASN.2016111178. Epub 2017 Jul 24.
8
Adherence to Antihypertensive Medication in Treatment-Resistant Hypertension Undergoing Renal Denervation.接受肾去神经支配治疗的顽固性高血压患者对抗高血压药物的依从性
J Am Heart Assoc. 2016 Feb 12;5(2):e002343. doi: 10.1161/JAHA.115.002343.
9
NKCC1 and NKCC2: The pathogenetic role of cation-chloride cotransporters in hypertension.NKCC1和NKCC2:阳离子-氯离子协同转运蛋白在高血压发病机制中的作用
Genes Dis. 2015 Jun;2(2):186-196. doi: 10.1016/j.gendis.2015.02.007.
10
Medication use in the neonatal intensive care unit.新生儿重症监护病房的药物使用情况。
Am J Perinatol. 2014 Oct;31(9):811-21. doi: 10.1055/s-0033-1361933. Epub 2013 Dec 17.

建立、验证和应用 UHPLC-MS/MS 法测定婴儿尿液样本中呋塞米的含量。

Development, validation, and implementation of an UHPLC-MS/MS method for the quantitation of furosemide in infant urine samples.

机构信息

Center for Clinical Pharmacology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Division of Neonatology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

出版信息

Biomed Chromatogr. 2022 Mar;36(3):e5262. doi: 10.1002/bmc.5262. Epub 2021 Nov 28.

DOI:10.1002/bmc.5262
PMID:34648199
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8881385/
Abstract

Furosemide is a diuretic drug used to increase urine flow in order to reduce the amount of salt and water in the body. It is commonly utilized to treat preterm infants with chronic lung disease of prematurity. There is a need for a simple and reliable quantitation of furosemide in human urine. We have developed and validated an ultra-high performance liquid chromatography-tandem mass spectrometry method for furosemide quantitation in human urine with an assay range of 0.100-50.0 μg/ml. Sample preparation involved solid-phase extraction with 10 μl of urine. Intra-day accuracies and precisions for the quality control samples were 94.5-106 and 1.86-10.2%, respectively, while inter-day accuracies and precision were 99.2-102 and 3.38-7.41%, respectively. Recovery for furosemide had an average of 23.8%, with an average matrix effect of 101%. Furosemide was stable in human urine under the assay conditions. Stability for furosemide was shown at 1 week (room temperature, 4, -20 and -78°C), 6 months (-78°C), and through three freeze-thaw cycles. This robust assay demonstrates accurate and precise quantitation of furosemide in a small volume (10 μl) of human urine. It is currently being implemented in an ongoing pediatric clinical study.

摘要

呋塞米是一种利尿剂药物,用于增加尿液流量,以减少体内的盐和水。它通常用于治疗患有早产儿慢性肺疾病的早产儿。需要有一种简单可靠的方法来定量测定人尿中的呋塞米。我们已经开发并验证了一种超高效液相色谱-串联质谱法,用于定量测定人尿中的呋塞米,检测范围为 0.100-50.0μg/ml。样品制备涉及固相萃取,使用 10μl 尿液。质量控制样品的日内准确度和精密度分别为 94.5-106%和 1.86-10.2%,而日间准确度和精密度分别为 99.2-102%和 3.38-7.41%。呋塞米的平均回收率为 23.8%,平均基质效应为 101%。呋塞米在检测条件下在人尿中稳定。呋塞米在 1 周(室温、4°C、-20°C 和-78°C)、6 个月(-78°C)和三个冻融循环中表现出稳定性。这种强大的检测方法可准确、精密地定量测定 10μl 小体积人尿中的呋塞米。它目前正在一项正在进行的儿科临床研究中实施。